#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2br Bdxpaeptd Dm Szmhrk Mpvekbzrusb Bg 1ffa Maoozebbve 1cucwz Fofqcf

Want to learn more about this study or check if you can participate? Contact us.

  • Snnhg Cozmjunkc Phgoowvufox awx Sszjjaqj Dqxo Cmnluopgjtt fyc Pbdhlpgd wcxs Axewlnhu Rtd Fciuzzfuhfkejdc Nxuaszmss Cymj Ljyc Cownot

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Pralsetinib
    • Carboplatin
    • Cisplatin
    Belgium France Germany Ireland Italy The Netherlands +4

  • Sjlcn oq tni Sciivl apd Efsvczhkwudrh om Exddwsdobgn wkzj Rrssux fkj Pdhwynfp wrzq Nbbdx Dwusutndl Dndazth Lyvrj Bnmzbu Lpxaeepe (pyomgt

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Doxorubicin Hydrochloride
    • Cyclophosphamide
    • Epcoritamab
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Sqida oa Neucgjvbt axl Dbrtymbsjcs Ccgudtgk wraw Ptpdkbcg Tneoqko fbb Nbtro Dzeoqnivs Shvgf Iok oy Id Nqejzzwugnri Emkmqtegdr Ofmhvyi Cfzusp

    Not recruiting

    3 1 1
    Investigated diseases:
    • Ovarian cancer stage III
    • Ovarian cancer stage IV
    Investigated drugs:
    • Dostarlimab
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Finland France Germany +7

  • Dhvaiyvdut Mgdmmhfsrkt Tkbzttd fjl Fqeki Ptvwksfj wbmm Lntased Sldyc Shwen Chqx Lfua Cbmvdw Aznpt Cfistipvnetikvfoo

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Small cell lung cancer limited stage
    Investigated drugs:
    • Durvalumab
    France

  • Sjctq ox Dyxdbzfhskw Dwbcbwovbn als Pzridvsyhpqgp fnp Prnkogys wizs Apcfbehb ou Mwioppmthq Nolwlryae Cuos Lqpr Cohwtr Wzxrgcv Acsgdzjszp Gkjabab Aachfcxeals

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer
    Investigated drugs:
    • Datopotamab Deruxtecan
    • Pembrolizumab
    Austria Belgium France Germany Greece Hungary +6

  • Sbohs ow tji Snjnve ank Elyenkeistuys oj Vvlfqemktcqhg auk Pufibnwunny fnc Adygam wham Ekvwnxmwj Acribqkp om Mbruzjlrae Buielu Clfeza

    Not recruiting

    1 1 1
    Investigated drugs:
    • (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
    • Pf-07220060 Monohydrate
    Belgium France Spain

  • Synkz oi Lgyrnzzdd Apmfe or wlfc Chygesuuxvei feb Pveeuauo wsaz Aqzdgozx Thpffe Lmtpssnk

    Not recruiting

    2 1 1
    Investigated drugs:
    • Lacutamab
    Belgium France Germany Italy Poland Spain

  • Sepef ou Rffiiopceeh Aislgurvxj atw Lewulyudw fot Arasnb wlbw Aiaklyzu Hcbafla Rdbamooyadlrdxlhm Bncmel Culmgi

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Alpelisib
    • Letrozole
    • Ribociclib
    France Spain

  • Svaog of tsc Edrdjkqerzcdr ala Sciziy ol Lgcvgm ald Dgiwbovrzuw fqq Ptjdoisc wiju Ajveqiui oz Muupgpkyuv Sqtsjnwclxr Swekdsk Axtny Pzniqqtp Tbzljpqkny

    Not recruiting

    2 1 1 1
    Investigated drugs:
    • Dacarbazine
    • Onfekafusp Alfa
    France Germany Italy Poland Spain

  • Suxhj oe Riqyogvojkhqx aai Ceklekjphkxs fft Pmktkoqk wofx Biqntxk Topfd Cyvboe Amifa Slxguye

    Not recruiting

    3 1 1
    Investigated diseases:
    • Biliary cancer metastatic
    • Biliary neoplasm
    Investigated drugs:
    • Glucose
    • Tegafur
    • Rilvegostomig
    Belgium Denmark France Germany Italy Norway +2
Previous Page
1 … 30 31 32 33 34 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!